Inari Medical—now part of Stryker—has today announced the launch of its next-generation InThrill thrombectomy system.
The company has stated in a recent press release that this is the first and only purpose-built small vessel and arteriovenous (AV) access thrombectomy system that can deliver fast, full luminal clot removal.
The second generation InThrill thrombectomy system is an 8Fr over-the-wire system comprising the InThrill thrombectomy catheter and the InThrill sheath. InThrill is built upon a familiar platform, optimised to become the standard for AV access and small vessel thrombectomy. Offering unmatched efficiency and clot removal, InThrill has distinctive features which include:
- Increased radial force for improved luminal wall apposition for optimised clot removal
- Offset single open mouth to optimise clot capture and removal
- Internal struts for even clot distribution within the element
- Redesigned backend to streamline ergonomics and improve the user experience
On May 19, 2025, Joshua Pinter and Anish Ghodadra of the University of Pittsburgh Medical Center (UPMC) performed the first commercial case using the new InThrill thrombectomy system. “The next generation of InThrill has made our thrombectomies more effective and consistent than ever,” said Pinter. “Inari’s dedication to building a small vessel tool has changed our paradigm of treatment for AV access thrombectomy,” added Ghodadra.
“The launch of the next-generation InThrill thrombectomy system reflects our deep commitment to solving real-world challenges in vascular care,” said Tim Lanier, president, Inari Division. “This latest innovation delivers new tools and enriches our work with physicians in the vascular space.”
